Feedback / Questions
picibanil biosimilar (TARA-002) - Protara Therap
https://www.globenewswire.com/news-release/2026/01/22/3223680/0/en/Protara-Therapeutics-to-Present-Updated-Interim-Data-from-Phase-2-ADVANCED-2-Trial-of-TARA-002-in-BCG-Unresponsive-NMIBC-Patients-at-the-ASCO-Genitourinary-Cancers-Symposium.html
Jan 22, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next